Delivery Order SPE2DB20D1110-SPE2DB26FJ68E
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,014.61 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on April 29, 2025, with a completion date of April 30, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,522.97 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, awarded on July 25, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,837.96 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract valued at $5,724.78. The award was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from...
- The Defense Logistics Agency awarded a $40,124.33 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor that supplies medications and medical supplies to military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) valued at $1,634.22, with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical supply will be delivered to the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,148.50 for 90-tablet supplies of Gemtesa 75 mg tablets under a firm fixed-price contract. The award, made on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded, non-set-aside procurement. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) valued at $6,194.63. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $3,326.40 delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $66,466.00 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on September 27, 2025, with completion targeted for September 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB26FJ68EDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,489.55 to AmerisourceBergen Drug Corp for 90 tablets of Gemtesa 75 mg, with an ultimate completion date of October 16, 2025. This non-set-aside contract represents a firm fixed-price delivery order under DLA's pharmaceutical supply operations, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through competitive acquisition processes and its significant role in the Department of Defense's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 10/15/25 |